{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:32:55Z","timestamp":1794961975814,"version":"4.9.1"},"posted":{"date-parts":[[2021,3,1]]},"group-title":"In Review","reference-count":0,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2021,2,22]]},"abstract":"<title>Abstract<\/title>\n        <p><bold>Background. <\/bold>COVID-19, caused by SARS-CoV-2, can involve sequelae and other medical complications that last weeks to months after initial recovery, which has come to be called Long-COVID or COVID long-haulers. This systematic review and meta-analysis aims to identify studies assessing long-term effects of COVID-19 and estimates the prevalence of each symptom, sign, or laboratory parameter of patients at a post-COVID-19 stage. <bold>Methods<\/bold>. LitCOVID (PubMed and Medline) and Embase were searched by two independent researchers. All articles with original data for detecting long-term COVID-19 published before 1<sup>st<\/sup> of January 2021 and with a minimum of 100 patients were included. For effects reported in two or more studies, meta-analyses using a random-effects model were performed using the MetaXL software to estimate the pooled prevalence with 95% CI. Heterogeneity was assessed using <italic>I<\/italic><sup>2<\/sup> statistics. This systematic review followed Preferred Reporting Items for Systematic Reviewers and Meta-analysis (PRISMA) guidelines, although the study protocol was not registered. <bold>Results.<\/bold> A total of 18,251 publications were identified, of which 15 met the inclusion criteria. The prevalence of 55 long-term effects was estimated, 21 meta-analyses were performed, and 47,910 patients were included. The follow-up time ranged from 14 to 110 days post-viral infection. The age of the study participants ranged between 17 and 87 years. It was estimated that 80% (95% CI 65-92) of the patients that were infected with SARS-CoV-2 developed one or more long-term symptoms. The five most common symptoms were fatigue (58%), headache (44%), attention disorder (27%), hair loss (25%), and dyspnea (24%). All meta-analyses showed medium (n=2) to high heterogeneity (n=13). <bold>Conclusions<\/bold>. In order to have a better understanding, future studies need to stratify by sex, age, previous comorbidities, the severity of COVID-19 (ranging from asymptomatic to severe), and duration of each symptom. From the clinical perspective, multi-disciplinary teams are crucial to developing preventive measures, rehabilitation techniques, and clinical management strategies with whole-patient perspectives designed to address long COVID-19 care.<\/p>","DOI":"10.21203\/rs.3.rs-266574\/v1","type":"posted-content","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T23:38:15Z","timestamp":1614641895000},"source":"Crossref","is-referenced-by-count":181,"title":["More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis"],"prefix":"10.21203","author":[{"given":"Sandra","family":"Lopez-Leon","sequence":"first","affiliation":[{"name":"Novartis Pharmaceuticals"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Wegman-Ostrosky","sequence":"additional","affiliation":[{"name":"Instituto Nacional de Cancerolog\u00eda: Instituto Nacional de Cancerologia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Perelman","sequence":"additional","affiliation":[{"name":"National Autonomous University of Mexico: Universidad Nacional Autonoma de Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda","family":"Sepulveda","sequence":"additional","affiliation":[{"name":"Harvard University T H Chan School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Rebolledo","sequence":"additional","affiliation":[{"name":"Emory University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Cuapio","sequence":"additional","affiliation":[{"name":"Karolinska Institute: Karolinska Institutet"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6174-4113","authenticated-orcid":false,"given":"Sonia","family":"Villapol","sequence":"additional","affiliation":[{"name":"Houston Methodist Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-266574\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-266574\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T16:02:42Z","timestamp":1615996962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-266574\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":0,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-266574\/v1","relation":{},"subject":[],"published":{"date-parts":[[2021,3,1]]},"subtype":"preprint"}}